Daewon Co., Ltd. (KOSDAQ:007680)
2,945.00
-60.00 (-2.00%)
At close: Oct 8, 2026
Daewon Revenue
Daewon had revenue of 27.07B KRW in the quarter ending June 30, 2026, with 11.35% growth. This brings the company's revenue in the last twelve months to 107.27B, down -40.65% year-over-year. In the year 2025, Daewon had annual revenue of 112.12B, down -59.55%. That makes Daewon the 24,363rd largest company in the world by revenue and 1,405th in South Korea.
Revenue (ttm)
107.27B
Revenue Growth
-40.65%
P/S Ratio
0.36
Revenue / Employee
812.68M
Employees
132
Market Cap
38.94B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 112.12B | -165.06B | -59.55% |
| Dec 31, 2024 | 277.18B | -158.91B | -36.44% |
| Dec 31, 2023 | 436.09B | 77.78B | 21.71% |
| Dec 31, 2022 | 358.31B | 69.02B | 23.86% |
| Dec 31, 2021 | 289.30B | 89.08B | 44.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shinwha Intertek | 202.00B |
| Sangshin Electronics | 133.30B |
| Kyung Nam Pharm | 54.89B |
| Eagle Veterinary Technology Co.,Ltd | 44.73B |
| Kolmar BioTech | 40.30B |
| Wonbiogen | 37.80B |
| FORCS | 35.52B |
| Inspien,Inc. | 19.89B |